Patheon’s Bourgoin-Jallieu Operations, offers commercial scale manufacturing for a range of solid, semi-solid and liquid dosage forms. Packaging formats for solids include blisters (plastic and alu-cold formed) for tablets and capsules as well as powders filled in sachets. Liquids can be filled in a number of plastic and glass bottle formats. The manufacturing facility also includes production areas designed for solvent handling.
PDS Swindon offers integrated pharmaceutical development services for conventional, sterile, controlled release, and high-potency products. The company’s development capabilities include formulation, analytical development, clinical trial materials (CTM) and scale-up manufacturing.
Wes Wheeler, president and CEO of Patheon, said: “We are very pleased with the partnership we have developed with Sanofi-aventis over the past 10 years. The agreements mark another milestone in our relationship which was initiated through site acquisition and enables our mission to offer world-class facilities and expertise, with an unwavering focus on service quality.”